Saravanan Alamelu

Saravanan Alamelu

Auto-generated profile, based on publicly available information

Saravanan Alamelu

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Chidambaram-608002, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2025 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
KVKamalesh Balakumar Venkatesan
Kamalesh Balakumar Venkatesan
SASaravanan Alamelu
Saravanan Alamelu
MKManoj Kumar
Manoj Kumar
PPPugalendhi Pachaiappan
Pugalendhi Pachaiappan
This study investigates the synthesis, characterization and anticancer efficacy of nerolidol-loaded beta cyclodextrin polymeric nanoparticles (NER-βCD-NPs) against MCF-7 breast cancer cells. Nerolidol, a sesquiterpene with anti-inflammatory, antioxidant, antimicrobial and anticancer properties, faces challenges of poor solubility and bioavailability, limiting its therapeutic potential. Breast cancer, a leading cause of cancer-related deaths in women, necessitates alternative therapies with fewer side effects compared to conventional chemotherapy. NER-βCD-NPs were synthesized and characterized using UV-visible spectroscopy, fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), dynamic light scattering (DLS), zeta potential analysis and differential scanning calorimetry (DSC). Drug encapsulation efficiency and in vitro release were analyzed using HPLC, while molecular docking assessed NER-βCD interactions. Characterization confirmed successful nanoparticle synthesis. UV-visible spectra and FTIR indicated encapsulation-specific changes, SEM revealed surface morphology, and DLS, zeta potential and DSC analyses demonstrated increased size and stability. The encapsulation efficiency was 84.9%, with 86% NER release at pH 5.4 over 48 h. Docking studies supported strong binding between NER and βCD (binding energy: -3.55 kcal/mol). Cytotoxicity assays showed significant MCF-7 cell inhibition. Mechanistic studies revealed reactive oxygen species (ROS) generation, mitochondrial dysfunction, nuclear changes and cell cycle arrest in the G0-G1 phase. Molecular analysis demonstrated apoptosis through upregulation of Bax, Caspase 6, Caspase 9 and Cytochrome c, alongside Bcl-2 downregulation. These results highlight NER-βCD-NPs as a promising strategy for breast cancer therapy, offering targeted delivery and enhanced therapeutic efficacy while mitigating nerolidol limitations. Further studies are warranted to validate their potential in clinical applications.


5 September 2026 in Asian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
SMS. Megala
S. Megala
SPS.R. Paranthaman
S.R. Paranthaman
ARA. Rajabhuvaneswari
A. Rajabhuvaneswari
SASaravanan Alamelu
Saravanan Alamelu
GKG. Ram Kumar
G. Ram Kumar
KAK. Akshaya
K. Akshaya
The present study aimed to synthesize and characterize biogenic silver nanoparticles (AgNPs) using an aqueous leaf extract of Leucas aspera and evaluate their antibacterial and anticancer activities. Phytochemical screening revealed flavonoids, phenols, alkaloids, tannins, saponins, carbohydrates, glycolysis-related compounds and steroids. GC-MS analysis identified 25 phytoconstituents, including lupeol, β-sitosterol, γ-linolenic acid, palmitic acid, stearic acid and retinyl palmitate, which may contribute to AgNPs formation and biological activity. UV-Visible spectroscopy confirmed AgNPs formation through a characteristic SPR band at 415 nm, while XRD revealed a face-centered cubic crystalline structure with an average crystallite size of 86.08 nm. FTIR analysis indicated the involvement of phenolic and flavonoid functional groups in Ag+ reduction and nanoparticle stabilization. SEM, EDX, DLS and zeta potential analyses revealed near-spherical nanoparticles with an average particle size of 65.82 nm, hydrodynamic diameter of 118.74 nm, negative surface charge of -26.78 mV and 64.27 wt.% Ag composition. The synthesized AgNPs exhibited concentration-dependent antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa, with MIC and MBC values of 100 and 125 µg/mL, respectively. Furthermore, AgNPs showed enhanced cytotoxicity against HEp-2 laryngeal carcinoma cells with an IC50 value of 236.63 µg/mL.